Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B-cell lymphoma

Daniel, A; Ghez, D; Ravaiau, C; Cavalieri, D; Tournilhac, O; Herbaux, C; Roriz, M; Wemeau, M; Guillet, S; Bossard, JB; Helene, D; Kaphan, E; Caroline, R; Florence, L; Pierache, A; Michel, M; Godeau, B; Terriou, L

Daniel, A (通讯作者),Claude Huriez Univ Hosp, Dept Hematol, Rue Michel Polonowski, F-59000 Lille, France.;Terriou, L (通讯作者),Univ Lille, CHU Lille, Dept Internal Med & Clin Immunol, Rue Michel Polonowski, F-59000 Lille, France.

EUROPEAN JOURNAL OF HAEMATOLOGY, 2022; 109 (6): 719

Abstract

Background Autoimmune conditions in B-cell lymphomas are frequent. Steroids are standard of care, but many patients require other immunosuppressive ag......

Full Text Link